Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
81.16
+0.69 (0.86%)
At close: Jul 30, 2025, 4:00 PM
80.86
-0.30 (-0.37%)
After-hours: Jul 30, 2025, 7:59 PM EDT
Edwards Lifesciences Revenue
Edwards Lifesciences had revenue of $1.53B in the quarter ending June 30, 2025, with 13.29% growth. This brings the company's revenue in the last twelve months to $5.69B, up 9.50% year-over-year. In the year 2024, Edwards Lifesciences had annual revenue of $5.44B with 8.57% growth.
Revenue (ttm)
$5.69B
Revenue Growth
+9.50%
P/S Ratio
8.43
Revenue / Employee
$359,816
Employees
15,800
Market Cap
47.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.44B | 429.50M | 8.57% |
Dec 31, 2023 | 5.01B | 546.00M | 12.23% |
Dec 31, 2022 | 4.46B | -768.50M | -14.69% |
Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EW News
- 5 days ago - Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance - Benzinga
- 5 days ago - Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results - Benzinga
- 5 days ago - Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Edwards Lifesciences raises annual sales forecast on strong demand for heart devices - Reuters
- 6 days ago - Edwards Lifesciences Reports Second Quarter Results - Business Wire
- 7 days ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 12 days ago - Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025 - Business Wire
- 2 months ago - Edwards Lifesciences: With A Heart Beating Strong And Steady - Seeking Alpha